Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10

Aujourd'hui

06:00
Norgine B.V. today announced new data showing that there is a strong correlation between higher cleansing scores and increased polyp detection rate (PDR) and adenoma detection rate (ADR).      (Logo:...

06:00
Norgine B.V. a annoncé aujourd'hui la publication de nouvelles données qui indiquent une forte corrélation entre le score de nettoyage intestinal, le taux de détection des polypes (TDP) et le taux de détection des adénomes (TDA).      (Logo:...


20 avril 2018

14:50
Eli Lilly and Company today announced additional results from its global, randomized, double-blind, placebo-controlled Phase 3 RANGE trial evaluating CYRAMZA® (ramucirumab) in combination with docetaxel in patients with locally advanced or...

14:11
AUCKLAND, Nouvelle-Zélande, 20 avril 2018 /CNW/ -- Fisher & Paykel Healthcare Corporation Limited annonce aujourd'hui qu'une nouvelle recherche publiée dans l'International Journal of COPD (Journal international sur la bronchopneumopathie chronique...

14:07
Fisher & Paykel Healthcare Corporation Limited a annoncé aujourd'hui que de nouveaux travaux de recherche publiés dans l'International Journal of COPD démontrent les avantages significatifs de la thérapie nasale à haut débit au moyen du dispositif...

09:00
Indivior PLC (LON: INDV) today announced that it has filed a New Drug Submission (NDS) with Health Canada's Therapeutic Drugs Directorate for SUBLOCADEtm (buprenorphine extended-release) injection, for subcutaneous use, for the treatment of moderate...

08:01
Allergan plc , a leading global pharmaceutical company announced today that the company will share 25 presentations at the 70th Annual American Academy of Neurology (AAN) Meeting, including five oral podium presentations. Five presentations will...

08:00
New CE-IVD Fast Sepsityper® solution: for MALDI-Biotyper (MBT) identification (ID) of over 2,700 microbial species from Positive Blood Cultures (PBC) with less hands-on time; Novel CE-IVD MBT STAR®-Cepha kit: for rapid, functional antibiotic...

07:00
Midazolam Nasal Spray (USL261), is a nasally administered investigational midazolam formulation intended as a rescue treatment of acute repetitive seizures (ARS) in patients with epilepsy, which has completed Phase 3 clinical development and is ready...

05:42
NeuroVive Pharmaceutical AB  today announced that its mitochondrial myopathy project, NVP025, has been selected for an oral presentation at the prestigious Mitochondrial Medicine 2018 conference held on 9-11 May in Cambridge, UK. The detailed...

02:45
Fisher & Paykel Healthcare Corporation Limited announced today that new research has been published in the International Journal of COPD which demonstrates significant benefits of nasal high flow therapy for COPD* patients using Fisher & Paykel...

01:00
Midazolam Nasal Spray (USL261), is a nasally administered investigational midazolam formulation intended as a rescue treatment of acute repetitive seizures (ARS) in patients with epilepsy, which has completed Phase 3 clinical development and is ready...


19 avril 2018

19:13
In the news release, Women Treated with Hologic's NovaSure® Endometrial Ablation System in New Study Reported Higher Amenorrhea Rates than Those Treated with Minerva, issued 19-Apr-2018 by Hologic, Inc. over PR Newswire, we are advised by the company...

16:42
Hologic, Inc. announced today that in a new study, women treated with NovaSure® endometrial ablation reported a higher one-year amenorrhea (absence of menstruation) rate, better quality of life (QoL) post-procedure, and greater satisfaction than...

16:05
Theravance Biopharma, Inc. ("Theravance Biopharma") today highlighted the publication in the New England Journal of Medicine (NEJM) of the landmark IMPACT study of Trelegy Ellipta in patients with chronic obstructive pulmonary disease (COPD). The...

14:02
Seqirus, a CSL company (ASX: CSL) and a leading innovator in influenza vaccines, today announced that The Lancet Respiratory Medicine published results from a Phase 3, randomized, head-to-head efficacy study that found an MF59® adjuvanted,...

13:18
IM HealthScience® (IMH) today announced favorable results from its Irritable Bowel Syndrome Safety Update at 24 Months (IBSSU-24), a real-world surveillance study reporting on the safety and tolerability profile of IBgard®. It is estimated that...

09:10
Sinovac Biotech Ltd. ("Sinovac " or the "Company"), a leading provider of biopharmaceutical products in China, today announced preliminary results of a phase III clinical study on Sabin inactivated polio vaccine ("sIPV") developed by Sinovac Biotech...

09:04
Le TFOS international Dry Eye WorkShop II (TFOS DEWS II), dont le rapport a été publié dans l'édition du mois de juillet 2017 de la revue Ocular Surface,[1] a reconnu que le tréhalose était un ingrédient efficace en combinaison avec l'acide...

09:00
Obesity is a major public health concern. Each year, millions of people die from obesity related diseases, such as diabetes and cardiovascular disease. Neuropeptide Y (NPY) is a highly abundant neuropeptide in the central nervous system and...

09:00
Le TFOS international Dry Eye WorkShop II (TFOS DEWS II), dont le rapport a été publié dans l'édition du mois de juillet 2017 de la revue Ocular Surface,[1] a reconnu que le tréhalose était un ingrédient efficace en combinaison avec l'acide...

08:39
L'obésité représente une préoccupation importante de santé publique. Chaque année, des millions de personnes meurent de troubles en relation avec l'obésité, comme le diabète et les maladies cardiovasculaires. Le neuropeptide Y (NPY) est le plus...

07:00
Manitoba, Saskatchewan, Alberta and Newfoundland are...

07:00
Erelzi a été ajouté au régime public d'assurance médicaments du Manitoba, de la Saskatchewan, de l'Alberta et de Terre Neuve, en fonction de critères précis pour le traitement des formes modérées ou graves de la polyarthrite rhumatoïde et pour...

04:00
Obesity is a major public health concern. Each year, millions of people die from obesity related diseases, such as diabetes and cardiovascular disease. Neuropeptide Y (NPY) is the most powerful stimulant of food intake and this effect is primarily...

03:00
Biohaven Pharmaceutical Holding Company Ltd. announced today that it will hold an investor event concurrently with the 2018 American Academy of Neurology (AAN) Annual Meeting in Los Angeles, from 6:00 p.m. to 7:30 p.m. PT on Sunday, April 22, 2018....


18 avril 2018

19:11
A preliminary study suggests that an investigational drug may help increase protein levels in babies with spinal muscular atrophy. The open-label study is released today and will be presented at the American Academy of Neurology's 70th Annual Meeting...

16:50
Entrinsic Health Solutions, Inc., an innovative health sciences company dedicated to the development and commercialization of amino acid-based technologies, today announced the publication of research showing that the beverage hydration index (BHI)...

13:40
Visikol Inc., established with an investment from Foundation Venture Capital Group (FVCG), an affiliate of New Jersey Health Foundation (NJHF), has secured a new round of funding led by industry executives, announced James M. Golubieski, president of...

12:00
Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study. The study, published online today in Blood Advances, a journal of the...

11:38
Northwell Health's Feinstein Institute for Medical Research President and CEO Kevin J. Tracey, MD, will present a Harvey Lecture on Thursday, April 19 at 8:00 pm at Rockefeller University's Caspary Hall. The Harvey Lecture is one of the oldest and...

10:39
Artelo Biosciences, Inc. , a biopharmaceutical company focused on the development of therapeutic treatments that modulate the endocannabinoid system, and The Research Foundation For The State University of New York (RF/SUNY), a not-for-profit...

09:00
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced presentations on amyotrophic lateral sclerosis (ALS) at the 70th Annual Meeting of the American Academy of Neurology (AAN) in Los Angeles, April 21-27....

09:00
Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced preclinical data on XmAb24306, an IL15/IL15-receptor...

09:00
Mercaptor Discoveries was founded to explore the potential of their core research team's discovery, "captons," in neuroprotection and to harness the power of these small molecules to treat brain injuries in situ, where the need is most urgent....

08:30
MabVax Therapeutics Holdings, Inc. , a clinical-stage oncology drug development company, announced today that three poster presentations on the Company's antibody development programs were made at the American Association for Cancer Research (AACR)...

07:00
AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, announced the publication of an analysis of the pharmacokinetic...

02:33
BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces that promising preclinical data with its lead AXL inhibitor bemcentinib (formerly...


17 avril 2018

17:27
People who have tried unsuccessfully to prevent migraine with other treatments may find relief with a drug called erenumab, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual...

16:28
A study finds middle schools with later start times, 8 a.m. rather than 7:20 a.m., help seventh and eighth grade students get an average of 17 minutes  more sleep each weeknight. This later start time helps students feel less tired and more alert...

16:00
Amgen today announced full results from the Phase 3b LIBERTY trial of Aimovigtm (erenumab) in episodic migraine patients who had previously failed two to four preventive treatments, due to lack of efficacy or to intolerable side effects.1 The data,...

14:05
Elios Therapeutics, a biopharmaceutical company developing innovative particle-delivered, dendritic cell vaccines in oncology, today presented initial open-label results from the ongoing Phase 2b clinical trial of the TLPLDC (tumor lysate,...

14:00
Trovagene, Inc. , a clinical-stage oncology therapeutics company, developing targeted therapeutics for the treatment of hematologic and solid tumor cancers, today announced the presentation of pharmacodynamic and biomarker data from the first patient...

14:00
DelMar Pharmaceuticals, Inc. ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that the Company presented a positive update on its two ongoing clinical...

12:11
Ionis Pharmaceuticals, Inc. , the leader in antisense therapeutics, today announced that Ionis and its collaborators will present data from its neurological disease programs at the 70th American Academy of Neurology (AAN) meeting in Los Angeles,...

10:31
Eiger BioPharmaceuticals, Inc., today announced additional positive lonafarnib (LNF) data from the LOWR HDV (LOnafarnib With Ritonavir in Hepatitis Delta Virus) Program presented at The International Liver Congresstm 2018, in Paris, France.  A...

10:10
PharmaJet®, the maker of innovative, needle-free injection technology, today announced that Vaccibody AS has received approval to start their cancer neoantigen trial using the PharmaJet Stratis® needle-free injection system.   Vaccibody, a...

09:37
Fervent Pharmaceuticals has announced the launch of clinical trials for their promising new post-menopausal drug therapy, FP-101. This two-month Phase 2a clinical trial, which involves 112 patients from across the Southeast, will assess the...

09:36
University of Nevada, Reno School of Medicine (UNR Med) Associate Professor Seungil Ro, Ph.D., in the Department of Physiology and Cell Biology, has made an important discovery, finding a molecule that can be used to inhibit and treat Type 2...

09:30
RTI International, a leading research institute, today announced a strategic collaboration with PierianDx, to help solve the problem of translating complex genomic data into actionable clinical insights to advance precision medicine. The...

1 2 3 4 5 6 7 8 9 10